Trending Articles

article thumbnail

STAT+: Cancer therapy’s new ‘gold rush’:  bispecific antibodies that hit key combination of targets

STAT

Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Merck’s Keytruda has been used against dozens of different cancers in millions of patients, making it the top-selling drug in the world, with over $25 billion in revenue in 2023.

Immunity 339
article thumbnail

Beyond copays: Redefining assistance for those with rare diseases and chronic conditions

PharmaVoice

Accessia Health helps ease the burden of managing a rare disease or chronic condition.

189
189
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: Dementia risk, higher than thought, requires a national strategy

STAT

A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that the risk of dementia increases with age is well described. What’s new and startling about this result is the number. It’s double prior estimates. The investigator team, led by researchers at New York University and funded by the National Institutes of Health, reported even higher risk estimates for women, people who self-report Black racial identi

358
358
article thumbnail

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

LifeProNow

January 14, 2025: “AskBio Inc, a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced that the first participants have been randomized in its Phase II clinical trial in patients with Parkinsons disease (PD). The randomization of the first participants in REGENERATE-PD is positive news for people living with Parkinsons disease and the physicians treating them, said Dr Rajesh Pahwa, MD, Director, Parkinson’s Disease and Movement Disorder C

130
130
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Pharmacy closures: Warning over 'serious, unintended consequences' on patients

The Pharmacist

Fresh concerns have been raised around the 'serious, unintended consequences' that ongoing pharmacy closures could have on patients following new analysis on the situation. The National Pharmacy Association (NPA) has today revealed 222 pharmacies closed permanently in 2024 the second highest annual closure rate on record and second only to the previous year.

132
132
article thumbnail

‘The bar has risen’: China’s biotech gains push US companies to adapt

BioPharma Dive

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare Conference.

144
144

More Trending

article thumbnail

By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years

PharmaVoice

The J.P. Morgan Healthcare Conference has been a focal point for M&A year after year, and after a quiet period, the deals are back on the table.

186
186
article thumbnail

CDC wants faster testing for bird flu in hospitals

pharmaphorum

Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.

Hospitals 119
article thumbnail

Streamlining mesenchymal stem cell (MSC) expansion

Pharmaceutical Technology

With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility and potential.

118
118
article thumbnail

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

BioPharma Dive

AbbVie's CEO hinted his company may be less willing to invest in psychiatry after a costly setback, while Lilly explained what it got wrong forecasting GLP-1 drug demand.

122
122
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Alcohol labels should carry ‘Alcohol Facts’ box listing nutrition and allergens, regulator says

STAT

Labels on alcohol could soon feature more thorough information on allergens and nutritional value, if a set of new proposals from the U.S. Treasury Department is approved.  On Friday the Alcohol and Tobacco Tax and Trade Bureau, or TTB, published a couple of proposed rules: One that would add an “Alcohol Facts” box — akin to “Nutrition Facts” on food products — to drinks, and another would require companies to disclose if alcohol contains any major

Labelling 294
article thumbnail

After an obesity stumble, BioAge reconnects with its longevity pipeline

PharmaVoice

The company is kicking off the year with a new Novartis partnership and renewed focus on metabolic aging targets.

130
130
article thumbnail

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

LifeProNow

January 15, 2025 : “Johnson & Johnsonannounced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug Administration for TAR-200 for the treatment of patients with Bacillus Calmette-Gurin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

Packaging 100
article thumbnail

AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025

Pharma Times

Preclinical data highlights potential in treating Alzheimer's disease

113
113
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Moderna gets $590M from US government for bird flu vaccine

BioPharma Dive

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.

Vaccines 120
article thumbnail

In pharma’s competitive climate, companies need evidence beyond clinical trials

PharmaVoice

Early planning and market research are crucial in an era of rising cost pressures.

130
130
article thumbnail

Sun Pharma unit poised to buy Canadian biotech Antibe

pharmaphorum

Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation

111
111
article thumbnail

Datapharm expands into US market through partnership with phactMI

Pharma Times

Collaboration aims to enhance accessibility of medicines information

111
111
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world

BioPharma Dive

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his team of dealmakers can juggle them.

120
120
article thumbnail

STAT+: A reporter’s JPM notebook: a look ahead for biopharma VC investing

STAT

SAN FRANCISCO — The J.P. Morgan Healthcare Conference isn’t just a venue for companies in the industry to outline their plans for the year or tamp down questions about their finances. The week is also a time for many venture capitalists to meet with startups or other investors to make plans for the year. So, what are their plans for new investments?

297
297
article thumbnail

Innovate or perish: Industry’s evolution leaves little room for me-too approaches

PharmaVoice

Novel drug approvals have set the stage for more breakthroughs in pharma.

130
130
article thumbnail

NVIDIA champions Innophore partnership to model drug dynamics with AI

Pharmaceutical Technology

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

107
107
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

Pharma Times

New partnership to advance precision medicine in lung cancer diagnosis

109
109
article thumbnail

Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

BioPharma Dive

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

article thumbnail

STAT+: Eleos raises $60 million for AI scribe for behavioral health providers

STAT

Eleos Health, maker of a product that generates clinical notes from audio of behavioral health appointments, has raised $60 million on the bet that therapy is different enough from other health care that providers need entirely different software. The rise of large language models that can efficiently summarize text has fueled the rapid development of companies using the technology to take documentation burden off overworked clinicians.

article thumbnail

‘The bar has risen’: China’s biotech gains push US companies to adapt

PharmaVoice

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder.

130
130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecast

Pharmaceutical Technology

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

105
105
article thumbnail

EC approves lazertinib in combination with amivantamab for NSCLC patients

Pharma Times

Combination therapy shows superior survival benefit over standard treatment

109
109
article thumbnail

Covid inquiry: 'Missed opportunity' to utilise pharmacies in vaccine roll-out

The Pharmacist

There was a 'missed opportunity' to make use of the community pharmacy sector during the early stages of the Covid-19 vaccination programme roll-out, an inquiry has been told. Speaking on behalf of the National Pharmacy Association, lawyer Deirdre Domingo also asked the UK Covid-19 Inquiry to consider whether there was 'a broader tendency' to overlook […] The post Covid inquiry: 'Missed opportunity' to utilise pharmacies in vaccine roll-out appeared first on The Pharmacist.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

258
258
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.